Shire’s $5.2bn bet on NPS

Once the prey, now the predator, Shire makes its biggest acquisition by buying the US biotechnology company NPS for $5.2bn. Lex’s Oliver Ralph and Robert Armstrong discuss the growing risks mid-sized pharmaceutical groups must take.

Make better investment decisions with Lex

Click here for more Lex videos

For more video content from the Financial Times, visit

Subscribe to the Financial Times on YouTube;

About the Author
Forex Alchemy is your daily source of cutting edge information, tips, tools, articles, analysis from across the Forex trading industry. If you would like to guest post or contribute regular articles on Forex Alchemy then please contact us here.

Leave a Reply